ProQR Therapeutics (PRQR) Deferred Taxes (2020 - 2024)
ProQR Therapeutics (PRQR) posted Deferred Taxes of -$215377.5 for Q2 2024, down 6708.53% sequentially from $3259.1 in Q1 2024.
ProQR Therapeutics (PRQR) Deferred Taxes (2020 - 2024) Analysis & Trends
ProQR Therapeutics has reported Deferred Taxes for 5 years, with the latest figure at -$215377.5 in Q2 2024.
- Quarterly Deferred Taxes changed N/A year-over-year to -$215377.5 in Q2 2024, while the trailing twelve-month figure through Sep 2024 was -$302471.4 (down 3694.25% YoY) and the FY2021 annual result came in at $138457.5, down 2.21% from the prior year.
- Deferred Taxes retreated to -$215377.5 in Q2 2024 per PRQR's latest filing, from $3259.1 in the prior quarter.
- Over five years, Deferred Taxes peaked at $87605.8 in Q3 2020 and troughed at -$215377.5 in Q2 2024.
- A 5-year average of $6156.8 and a median of $21341.1 in 2022 frame the typical range for Deferred Taxes.
- The sharpest annual moves came in 2021 and 2023: Deferred Taxes surged 426.79% in 2021, then tumbled 229.87% in 2023.
- Over 5 years, Deferred Taxes stood at $45307.0 in 2020, then slumped by 44.45% to $25167.4 in 2021, then surged by 176.43% to $69570.9 in 2022, then sank by 229.87% to -$90353.0 in 2023, then slumped by 138.37% to -$215377.5 in 2024.
- According to Business Quant data, Deferred Taxes over the past three periods registered -$215377.5, $3259.1, and -$90353.0 for Q2 2024, Q1 2024, and Q3 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -137,876.64 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.66 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | ProQR Therapeutics | 206.80 Mn | 111.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -215,377.52 |
| Mar 31, 2024 | 3,259.09 |
| Sep 30, 2023 | -90,353.01 |
| Sep 30, 2022 | 69,570.93 |
| Jun 30, 2022 | 21,341.13 |
| Mar 31, 2022 | 7,856.36 |
| Dec 31, 2021 | 25,167.36 |
| Sep 30, 2021 | 41,275.06 |
| Jun 30, 2021 | 63,826.39 |
| Mar 31, 2021 | 8,443.65 |
| Dec 31, 2020 | 45,307.01 |
| Sep 30, 2020 | 87,605.79 |
| Jun 30, 2020 | 12,116.06 |